Demo Sign up Log In

Protagonist Therapeutics Inc (PTGX)

Cash Conversion Ratio

1.34×

Quarterly · Period ending: Jun 30, 2026

PTGX Cash Conversion Ratio

Latest reported1.34×period endingJun 30, 2026

Latest reported1.34×period endingJun 30, 2026

PTGX Quarterly Cash Conversion Ratio (-8.40× → 1.34×)

Latest values, visible window

High-resolution chart · PNG

PTGX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protagonist Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	1.3441×
Mar 31, 2026	-12.9944×
Dec 31, 2025	0.8005×
Sep 30, 2025	0.0515×
Jun 30, 2025	0.8511×
Mar 31, 2025	-10.7094×
Dec 31, 2024	-0.2239×
Sep 30, 2024	0.8623×
Jun 30, 2024	-8.773×
Mar 31, 2024	-0.1335×
Dec 31, 2023	0.6198×
Jun 30, 2022	0.3393×
Mar 31, 2022	1.8127×
Dec 31, 2021	0.7352×
Sep 30, 2021	0.85×
Jun 30, 2021	0.7846×
Mar 31, 2021	1.2041×
Dec 31, 2020	1.0056×
Sep 30, 2020	2.1077×
Jun 30, 2020	1.113×
Mar 31, 2020	0.7961×
Dec 31, 2019	0.8289×
Sep 30, 2019	0.8494×
Jun 30, 2019	-0.0952×
Mar 31, 2019	1.1932×
Dec 31, 2018	0.7354×
Sep 30, 2018	1.0789×
Jun 30, 2018	1.7853×
Mar 31, 2018	2.0031×
Dec 31, 2017	4.6543×
Sep 30, 2017	-8.3967×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.